Repository logo
 
Publication

Portuguese Recommendations for the Use of Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis - 2020 Update

2022-01Journal article Open access
Simple item page
dc.contributor.authorFernandes, BM
dc.contributor.authorGuimarães, F
dc.contributor.authorAlmeida, DE
dc.contributor.authorNeto, A
dc.contributor.authorTavares-Costa, J
dc.contributor.authorRoxo Ribeiro, A
dc.contributor.authorQuintal, A
dc.contributor.authorPereira, JP
dc.contributor.authorSilva, L
dc.contributor.authorNóvoa, TS
dc.contributor.authorFaustino, A
dc.contributor.authorVaz, C
dc.contributor.authorKhmelinskii, N
dc.contributor.authorSamões, B
dc.contributor.authorDourado, E
dc.contributor.authorSilva, JL
dc.contributor.authorBarcelos, A
dc.contributor.authorMariz, E
dc.contributor.authorGuerra, M
dc.contributor.authorSantos, MJ
dc.contributor.authorSilvério-António, M
dc.contributor.authorTeixeira, RL
dc.contributor.authorRomão, VC
dc.contributor.authorSantos, H
dc.contributor.authorSantos-Faria, D
dc.contributor.authorAzevedo, S
dc.contributor.authorRodrigues, A
dc.contributor.authorDias, JM
dc.contributor.authorLopes, C
dc.contributor.authorPinto, P
dc.contributor.authorCouto, M
dc.contributor.authorMiranda, LC
dc.contributor.authorBernardo, A
dc.contributor.authorCruz, M
dc.contributor.authorTeixeira, F
dc.contributor.authorMourão, AF
dc.contributor.authorNeto, A
dc.contributor.authorTeixeira, V
dc.contributor.authorCordeiro, A
dc.contributor.authorBarreira, S
dc.contributor.authorInês, LS
dc.contributor.authorCapela, S
dc.contributor.authorSepriano, A
dc.contributor.authorCanhão, H
dc.contributor.authorFonseca, JE
dc.contributor.authorDuarte, C
dc.contributor.authorBernardes, M
dc.date.accessioned2024-02-21T15:28:16Z
dc.date.available2024-02-21T15:28:16Z
dc.date.issued2022-01
dc.description.abstractObjective: To update the recommendations for the treatment of rheumatoid arthritis (RA) with biological and targeted synthetic disease-modifying antirheumatic drugs (bDMARDs and tsDMARDs), endorsed by the Portuguese Society of Rheumatology (SPR). Methods: These treatment recommendations were formulated by Portuguese rheumatologists taking into account previous recommendations, new literature evidence and consensus opinion. At a national meeting, in a virtual format, three of the ten previous recommendations were re-addressed and discussed after a more focused literature review. A first draft of the updated recommendations was elaborated by a team of SPR rheumatologists from the SPR rheumatoid arthritis study group, GEAR. The resulting document circulated among all SPR rheumatologists for discussion and input. The level of agreement with each of all the recommendations was anonymously voted online by all SPR rheumatologists. Results: These recommendations cover general aspects such as shared decision, treatment objectives, systematic assessment of disease activity and burden and its registry in Reuma.pt. Consensus was also achieved regarding specific aspects such as initiation of bDMARDs and tsDMARDs, assessment of treatment response, switching and definition of persistent remission. Conclusion: These recommendations may be used for guidance of treatment with bDMARDs and tsDMARDs in patients with RA. As more evidence becomes available and more therapies are licensed, these recommendations will be updated.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationARP Rheumatol . 2022 Jan-Mar;1(1):63-82.pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/4806
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSociedade Portuguesa de Reumatologiapt_PT
dc.subjectHSAC REUMpt_PT
dc.subjectConsensuspt_PT
dc.subjectHumanspt_PT
dc.subjectAntirheumatic Agents* / therapeutic usept_PT
dc.subjectArthritis, Rheumatoid* / drug therapypt_PT
dc.subjectPortugal / epidemiologypt_PT
dc.subjectRheumatologypt_PT
dc.titlePortuguese Recommendations for the Use of Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis - 2020 Updatept_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage82pt_PT
oaire.citation.startPage63pt_PT
oaire.citation.titleARP Rheumatologypt_PT
oaire.citation.volume1pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ARP Rheumatol.pdf
Size:
197.28 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

REUM - Artigos